NCT04060836 - Pharmacokinetics Evaluation of Recombinant Coagulation Factor VIII Injection in Subjects With Hemophilia A. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 8, 2019

Primary Completion Date

March 31, 2020

Study Completion Date

March 31, 2020

Conditions

Hemophilia A

Interventions

DRUG

Xyntha

Recombinant Coagulation Factor VIII Injection produced by Pfizer Inc.

DRUG

Recombinant Coagulation Factor VIII Injection

A kind of Recombinant Coagulation Factor VIII Injection produced by sponsor.

Trial Locations (5)

RECRUITING

AnHui Provincial Hospital, Hefei

RECRUITING

Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin

RECRUITING

Xiangya Hospital Central South University, Changsha

RECRUITING

HeNan Cancer Provincial Hospital, Zhengzhou

RECRUITING

The First Hospital of LanZhou University, Lanzhou